Business plan book

table of Contents
Product background
2. Basic product overview
2.1 Cordyceps Overview
2.2 Cordyceps militaris
2.3 Artificial cultivation of the components of Cordyceps militaris
3. Product competitive advantage
3.1 Pharmacodynamic ingredients
3.2 Factory production
3.3 Low cost and stable supply
3.4 Self-owned intellectual property protection
4. Investment environment background
4.1 Western Development Policy
4.2 Overview of Yunnan, China
4.3 Overview of Yunnan Investment Environment
5. Investment and plant planning
5.1 Basic stock composition basket
5.2 Staff of the Board of Supervisors
5.3 Management team
5.4 Construction scale and budget
5.5 Sales Channel
6. Estimated revenue
6.1 Business objectives
6.2 Operating income
6.3 Financial Estimate
7 Conclusion

1. Background Cordyceps sinensis is commonly known as Cordyceps sinensis. It is a valuable Chinese herbal medicine. According to the "Compendium of Materia Medica", "The Herbal Fresh", "The Compendium of Materia Medica", etc., Cordyceps sinensis has "preserving lung and kidney, secreting qi, stopping bleeding and removing phlegm. The effect of all kinds of imaginary damages, specializing in life-threatening. Cordyceps has been listed as the top nourishing drug for thousands of years, and has the reputation of “Oriental Legendary Treasures”. However, due to the extremely high requirements for the natural growth of Cordyceps in nature, its production is extremely low and the supply is scarce. Therefore, its price has always remained high, which limits its scope of application and promotion.
With the general improvement of the economic conditions of Chinese at home and abroad at the end of the last century, and the gradual upgrading of the quality of life, the development of the global “predatory” of natural Cordyceps, coupled with the increasing destruction of the natural ecological environment, led to the natural Cordyceps resources. Increasingly exhausted.
According to statistics from authoritative departments, the annual global production of natural Cordyceps is less than 10 tons, and it is still decreasing year by year. And the annual market demand is far greater than its output, the contradiction of demand makes the price of Cordyceps higher, and the counterfeit and shoddy goods in the circulation field flood the market. [ )

4. Investment environment background
4.1 Western Development Policy Western development is a major strategic choice for China's economic development in the 21st century. It has been implemented since 2000. It is planned to take 5 to 10 years to make breakthroughs in infrastructure and ecological construction in the west. Progress is aimed at narrowing the gap between the East and the West, adjusting the industrial structure, optimizing resource allocation, and strengthening national unity. Since the beginning of the development of the western region, it has established institutions, promulgated preferential policies, and compiled master plans and accelerated the construction of major projects. The 10 major projects planned for construction have all started, and the progress is progressing smoothly; the investment in construction projects has completed more than 76 billion yuan, of which 40% of the projects have been completed and put into production. In 2001, the government formulated the implementation rules for preferential policies, carried out legislative work for the development of the western region, organized the implementation of the plan for the development of the western region, and started new constructions including the Qinghai-Tibet Railway, the West-East Gas Pipeline, returning farmland to forests and grasslands, and educational projects. The key projects have a total investment of 300 billion yuan.
With the state's financial resources, the company will implement direct development assistance including fiscal transfer payments and infrastructure investment, and use the state-owned policy resources to induce domestic and foreign capital, technology, talents and enterprises to “westward” and actively adjust the industrial structure. Local geography, climate and resources, etc., focus on the development of advantageous industries with their own characteristics,
Develop science and technology and education, accelerate personnel training, accelerate the transformation of scientific and technological achievements, increase reform and opening up, study new ideas, new methods, and new mechanisms to adapt to the new situation, and adopt some major policy measures to accelerate the pace of reform and opening up in the western region.
The country’s tilting investment policy to the west has prompted huge amounts of funds to drive all industries in an all-round way. The supply of products in these industries provides direct and potential development space for enterprises, and the development priorities set by local governments in the west.
Will give enterprises "policy guarantee" and "enjoy the biggest policy three-dimensional space", "reasonable regional adjustment function"
And “moderate relaxation of taxation systems, investment and financing”.
4.2 Overview of Yunnan, China:
Yunnan Province is located in the southwestern border of China. The province covers an area of ​​39,000 square kilometers, accounting for 4% of the country's total area.
Ranked eighth in the country. The southern part of the country borders Myanmar, Laos and Vietnam, and is adjacent to Thailand and India. The border line is 4,060 kilometers long.

Yunnan is located in the southwestern border of China. There are many ethnic minorities, rich in natural resources, and abundant natural minerals, animal and plant resources. However, due to the mountains and rivers in the territory, the hills are undulating. Since ancient times, the traffic has been inconvenient, except for the historic Nansi Road.
Even in the two basins that are next to each other, the people often have different situations of old and dying; the inconvenience of transportation not only makes the development and utilization of resources impossible, but also makes it difficult to communicate with the outside world, thus causing the people to be conservative.
In the past, this has greatly restricted the development of Yunnan. Similarly, the abundant resources here have been preserved relatively intact.
Since the reform and opening up, Yunnan Province has started to build on the infrastructure construction, and has made full development in transportation and energy. After more than ten years of hard work, the infrastructure of Yunnan Province has reached an unprecedented high level in history, goods and personnel. It has been able to circulate smoothly inside and outside the province, and electric power and water resources have been developed and fully utilized to meet demand. Today, Yunnan Province has shaken off the image of poverty, backwardness, and conservativeness in the past, and is poised for development in the “Western Development”. Under the policy, with its rich flora and fauna resources and a tourism environment full of ethnic culture and beauty, it will fly to the future.
4.3 Overview of Yunnan Investment Environment:
Yunnan enjoys the reputation of “plant kingdom”, “animal kingdom”, “flower home” and “hometown of medicinal materials”; mineral resources mainly composed of phosphorus and non-ferrous metals have large reserves and high concentration, phosphorus, copper and lead. 25 kinds of minerals such as zinc, the third largest in terms of planned reserves; the water is abundant, the theoretical reserves are 103.64 million kilowatts, and the developable installed capacity is
71.168 million kilowatts; Yunnan condenses a variety of climate types from the tropics to the frigid zone, with natural beauty and unique ethnic culture. The tourism resources are gradually matched and more reasonable.
4.3.1 Advantageous industries supported by Yunnan
A. Infrastructure construction: To realize the high-levelization of the “three horizontal and three vertical” road network for Yunnan, and form a traffic trunk line to support Yunnan's adjustment of productivity layout; Nankun, Nei Kun, Yunnan and Tibet, Pan-Asian Railway form China and Southeast Asia The railway network connecting South Asia and neighboring provinces; the construction of Kunming Second Airport, Nujiang, Honghe Civil Airport, the expansion of Jinghong and Mang citizens' airports, and laying the absolute status of Yunnan as China's fifth largest international airport.
B. Modern medicine industry based on natural medicine: focus on the development of new medicines based on Yunnan medicinal plants and animals; medicinal plants industrial products and national medicines.
C. Flower industry: Taking full advantage of the climatic conditions of Yunnan and the diversity of wild flower resources, Yunnan will be built into the country's largest flower production, export base and trading center.
D. Science and education is booming: developing education, attaching importance to quality education, and accelerating the training of all types of talents. In accordance with the principle of "co-construction, adjustment, cooperation, and merger", there are plans to implement joint education. Rational allocation and full use of educational resources,
Improve the quality of education and school benefits. Increase investment in education, and open the door to attract domestic and foreign funds to invest in education.
E, cultural and entertainment industry.
F. Electromechanical industry: aiming at the integration of machine optoelectronics, measured by market demand and expanded in a timely manner.
G, building materials industry.
H. Commercial and trade industry: Kunming will be built into a regional international trade center, and actively promote the construction of three border trade zones or bonded areas of Ruili, Hekou and Jinghong, and improve and improve the four secondary trade centers of Yuxi, Qujing, Dali and Kaiyuan.
I. Information industry.
J, bioengineering technology industry.

5. Investment and plant planning

5.2 Basic stock composition basket and staff of the Board of Supervisors
5.2.1 Share composition ★ The investor contributed RMB 3.6 million, accounting for 60% of the total share capital;
★Technical party with its technology and intellectual property rights, accounting for 35% of the total share capital;
★ Lianhua Company accounts for 5% of the total share capital of its intangible assets for Yunnan investment operations and business channels;
5.2.2 The staff of the board of directors ★ The sales and trading company has 5 directors, of which 2 seats are from the funder, 1 is from the technical side, and 1 is from the representative of Lianhua.
5.3 The chairman of the management team shall be appointed by the funder.
experience:

The managing director shall be appointed by a tripartite party to serve as a suitable person.
experience:

The deputy general manager and director of the board of directors shall be appointed by the technical party.
experience:

The deputy general manager of the director's business shall be appointed by the tripartite parties.
experience:

5.4 The scale and budget of the plant are to produce 80KG of dried Cordyceps sinensis fruit per month, and the mycelium 400KG is the initial scale.
Expense name Main content Amount of money Remarks Start-up fee
Office first year rent 48,000 100m2, urban office registration 8,000
Buy office wealth equipment 20,000 tables, chairs, telephones, faxes, computers, basic stationery, water dispensers, tea cups, etc. Buying vans 50,000 domestic Changhe vans to build a factory to purchase land 600,000 2600m2, suburban factory construction costs 880,000 2200m2, including office, Laboratory equipment, inoculation room, culture room, medium configuration room, etc. purchase office wealth management equipment 20,000 tables and chairs, telephone, fax, computer, basic stationery, water dispenser, tea cup, etc. 391,000 equipment including sterile super mirror workbench, microscope... ...and purchase van 50,000 domestic Changhe van liquidity reserve liquidity 1,533,000
Total investment amount 3,600,000

6. Estimated revenue
6.1 Business Objectives The 21st century is the century of biochemical technology. Today, as human life in the world gradually moves toward a well-off society, the pursuit of health and longevity has become an irreversible trend. Therefore, all major manufacturers have a variety of health and natural appeals. Products are introduced to the market; while these products appear, the early-stage chemical compounds are gradually disappearing in the market, replaced by general extracts of natural fungi, plants, animals or single extracts, or directly listed. Or as a pharmaceutical intermediate to be processed into high value-added pharmaceutical products, it is foreseeable that biochemical technology will dominate the star industry in this century and become a unique show.
According to the annual assessment report of the authoritative research institutions of the global pharmaceutical market, global pharmaceutical sales reached 343 billion US dollars in 1999, an increase of 12% over 1998, of which China only accounted for 22 billion US dollars. The report predicts that by 2004, global drug sales will reach $506 billion. In 1999, North America remained the world's largest pharmaceutical market, with pharmaceutical sales reaching $138.8 billion, an increase of 18% over the previous year. It is estimated that by 2004, sales of pharmaceuticals in North America will reach 234.37 billion US dollars, an average annual growth rate of 11%. Drug sales in Western Europe in 1999 were flat at $89.6 billion, but the report expects annual sales of pharmaceuticals to grow at an annual rate of 7.7% over the next five years. The Japanese pharmaceutical market was affected by the government’s policy of lowering drug prices once a year. Last year’s sales soared by 20% to $43.5 billion, but the report predicts an average annual increase of only 0.4% in pharmaceutical sales over the next five years. . The world's top ten pharmaceutical markets are mainly distributed in North America, Japan, Latin America and Europe. The United States is still the largest pharmaceutical market, with sales of $99.5 billion in 1998, followed by Japan; first place in Europe in Germany with $18.2 billion, and the top ten markets in 1998 accounted for 85% of global drug sales, market The total amount is 251.3 billion US dollars. In the next five years, the fastest growing regions are North America, the Middle East, Australia and Southeast Asia including China. 39% of pharmaceutical sales in 1998 were in North America, and the market is expected to reach $169 billion in sales by 2002.